Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, representing a minor administrative update to the page documentation.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now indicates recruitment is closed and introduces new guidance sections for reading the study record and joining the study, along with a formatting change to the Intervention/Treatment heading and a revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check28 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a newer version of the page's documentation/metadata.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a newer patch level has been applied to the page metadata. It signals a minor update to the page's versioning metadata and change log rather than alterations to core content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page’s footer software revision was updated from **v3.5.2** to **v3.5.3** without any stated changes to the underlying study details.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.